Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon), tirzepatide is a dual agonist (GLP-1 + GIP), and semaglutide is a single agonist (GLP-1)
For some, its the first time they feel like change is truly possible
Yes, as a research chemical for qualified researchers conducting in-vitro laboratory studies
Other rare adverse effects include pancreatitis and cholelithiasis
The semaglutide Afterpay guide and tirzepatide Afterpay options explain how to spread the cost of medication across multiple payments
Zepbound makes sense if you: Want to start treatment now under a licensed prescriber Value a drug with completed Phase 3 data and FDA approval Have insurance coverage or can use the self-pay vial program Prefer a known, regulated safety profile Retatrutide may interest you if you: Are tracking the most aggressive weight-loss results in development Did not reach your goal on tirzepatide and want to know what comes next Are willing to wait for FDA approval rather than buy unregulated material Want to discuss clinical trial enrollment with your doctor For people already on Zepbound who are curious about a future switch, the practical considerations are laid out in switching from tirzepatide to retatrutide
US$ 20.92
US$ 26.03
US$ 21.40
US$ 22.51
US$ 25.27
US$ 24.49
